Filing Details

Accession Number:
0001415889-16-006926
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-19 16:38:47
Reporting Period:
2016-08-17
Filing Date:
2016-08-19
Accepted Time:
2016-08-19 16:38:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1109196 Mabvax Therapeutics Holdings Inc. MBVX Pharmaceutical Preparations (2834) 930987903
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1186123 David John Hansen C/O Mabvax Therapeutics, Inc.
11535 Sorrento Valley Rd., Suite 400
San Diego CA 92121
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-17 3,119 $0.00 37,529 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Class A Warrant Acquisiton 2016-08-17 3,119 $0.00 3,119 $5.55
Common Stock Class B Warrant Acquisiton 2016-08-17 3,119 $0.00 3,119 $6.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,119 No 4 P Direct
3,119 No 4 P Direct
Footnotes
  1. Reporting Person paid $4.81 to purchase each share of Common Stock together with a Class A Warrant to purchase one share of Common Stock, and a Class B Warrant to purchase one share of Common Stock.
  2. Warrant is immediately exercisable and expires on the third anniversary of its issuance date